↓ Skip to main content

Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial

Overview of attention for article published in BMC Infectious Diseases, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
9 tweeters
facebook
1 Facebook page
video
1 video uploader

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial
Published in
BMC Infectious Diseases, November 2013
DOI 10.1186/1471-2334-13-556
Pubmed ID
Authors

Paulo Dornelles Picon, Marisa Boff Costa, Rafael da Veiga Picon, Lucia Costa Cabral Fendt, Maurício Leichter Suksteris, Indara Carmanim Saccilotto, Alicia Dorneles Dornelles, Luis Felipe Carissimi Schmidt

Abstract

The common cold and other viral airway infections are highly prevalent in the population, and their treatment often requires the use of medications for symptomatic relief. Paracetamol is as an analgesic and antipyretic; chlorphenamine is an antihistamine; and phenylephrine, a vasoconstrictor and decongestant. This randomized, double-blind, placebo-controlled trial sought to evaluate the efficacy and safety of a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine in the symptomatic treatment of the common cold and flu-like syndrome in adults.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
Peru 1 1%
Unknown 71 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 15%
Student > Master 9 12%
Researcher 8 11%
Professor > Associate Professor 8 11%
Other 8 11%
Other 13 18%
Unknown 16 22%
Readers by discipline Count As %
Medicine and Dentistry 30 41%
Pharmacology, Toxicology and Pharmaceutical Science 11 15%
Biochemistry, Genetics and Molecular Biology 4 5%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Other 5 7%
Unknown 17 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2020.
All research outputs
#1,380,569
of 17,362,547 outputs
Outputs from BMC Infectious Diseases
#329
of 6,154 outputs
Outputs of similar age
#21,151
of 271,626 outputs
Outputs of similar age from BMC Infectious Diseases
#26
of 579 outputs
Altmetric has tracked 17,362,547 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,154 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,626 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 579 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.